Reducing Distress in Type 2 Diabetes: Spotlight-AQ CGM Pilot Study
Research type
Research Study
Full title
Spotlight-AQ & real-time CGM Pilot Study: Achieving Parity of Esteem
IRAS ID
315237
Contact name
Katharine Barnard-Kelly
Contact email
Sponsor organisation
BHR Ltd
Duration of Study in the UK
0 years, 6 months, 29 days
Research summary
The current study (subject to this ethics application) aims to focus investigation on whether Spotlight-AQ can improve onboarding processes for people using real-time continuous glucose monitoring systems (CGM). The reason being that it is known such devices can be burdensome as well as beneficial. If Spotlight-AQ can improved tailored onboarding, it could achieve parity of esteem between physical and mental health outcomes and reduce the burden.
Aim: To determine the impact of specific tailored, patient-identified priority concerns on physical and mental health outcomes for adults with type 2 diabetes with sub-optimal glycaemic control.
Population: Adults with type 2 diabetes
Intervention: Spotlight-AQ in combination with real-time CGM
Comparator: Usual Care
Outcomes: Time in target glycaemic range; validated measure diabetes distress (DDS), glucose monitoring satisfaction (GMSS) and healthcare professional burnout (Maslach Burnout Inventory).
Time: 3-month interventionREC name
London - Fulham Research Ethics Committee
REC reference
22/PR/0578
Date of REC Opinion
17 Jun 2022
REC opinion
Further Information Favourable Opinion